Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESISTANCE-HF: Furoscix in Heart Failure
NCT05528588Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jun 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of furosemide in heart failure (HF), sponsored by UT Southwestern Medical Center. Started Jun 2023; status: completed.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05528588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05528588.